By Counterforce Health Team in HyperHEP (hepatitis B immune globulin) —

Get HyperHEP Covered by Cigna in Michigan: Appeals Guide and Medical Necessity Templates

Answer Box: Getting HyperHEP Covered by Cigna in Michigan

HyperHEP (hepatitis B immune globulin) requires prior authorization from Cigna for post-exposure prophylaxis. To get covered: (1) Your doctor submits a formulary exception request with exposure documentation and CDC guideline references within 24-48 hours of exposure, (2) If denied, file an internal appeal within 180 days, then (3) Request external review through Michigan DIFS within 127 days of final denial. Start today: Contact your prescriber to gather exposure documentation and vaccination history for the PA request.

Table of Contents

  1. Coverage at a Glance
  2. Policy Overview: How Cigna Covers HyperHEP
  3. Medical Necessity Requirements
  4. Step Therapy and Exception Pathways
  5. Quantity Limits and Dosing Guidelines
  6. Required Documentation
  7. Site of Care Requirements
  8. Appeals Process in Michigan
  9. Common Denial Reasons and Solutions
  10. FAQ
  11. Sources and Further Reading

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for most uses Cigna provider portal Cigna PA Requirements
Formulary Status May be non-formulary myCigna.com drug lookup Cigna Formulary Search
Timing Window Within 24 hours (ideal), up to 7 days post-exposure CDC guidelines CDC Post-Exposure Guidance
Site of Care In-network provider administration preferred Policy documents Express Scripts Specialty
Appeal Deadline 180 days for internal, 127 days for external Michigan insurance law Michigan DIFS

Policy Overview: How Cigna Covers HyperHEP

Cigna typically manages HyperHEP through its specialty pharmacy benefit, often administered by Express Scripts or Accredo. The drug falls under medical benefit coverage when administered in clinical settings, but may require pharmacy benefit management for dispensing.

Plan Types and Coverage

  • HMO/PPO Plans: Prior authorization required; formulary exception process available
  • Medicare Advantage: Enhanced PA requirements; step therapy may apply
  • Medicaid Plans: Follow state Medicaid guidelines with additional Cigna requirements
Note: Michigan's insurance market is dominated by Blue Cross Blue Shield (67% market share), but Cigna maintains significant presence with competitive formulary policies.

Medical Necessity Requirements

Cigna considers HyperHEP medically necessary when used according to CDC post-exposure prophylaxis guidelines for hepatitis B virus exposure.

FDA-Approved Indications

HyperHEP is approved for:

  • Post-exposure prophylaxis after percutaneous or mucosal exposure
  • Perinatal prophylaxis for infants born to HBsAg-positive mothers
  • Sexual exposure prophylaxis within 14 days
  • Adjunct therapy in certain transplant settings

Documentation Requirements

Your prescriber must document:

  1. Type and timing of exposure (needlestick, sexual contact, perinatal)
  2. Source patient HBsAg status (if known)
  3. Recipient's hepatitis B immunity status and vaccination history
  4. Reference to CDC guidelines for the specific exposure scenario
  5. Urgency justification if requesting expedited review

Step Therapy and Exception Pathways

While HyperHEP doesn't typically require step therapy for acute post-exposure use, Cigna may require documentation that hepatitis B vaccination alone is insufficient.

Exception Process

If HyperHEP is non-formulary, your prescriber can request a formulary exception by:

  1. Submitting Exception Request: Use Cigna's formulary exception form
  2. Clinical Justification: Explain why formulary alternatives are inappropriate
  3. Timeline: Cigna responds within 72 hours (24 hours for expedited requests)
Tip: For post-exposure scenarios, emphasize the time-sensitive nature and reference CDC's 24-hour optimal treatment window.

Quantity Limits and Dosing Guidelines

Standard Dosing by Indication

Indication Dose Route Cigna Coverage Limit
Perinatal prophylaxis 0.5 mL (110 IU) IM 1 dose per infant per birth
Adult post-exposure 0.06 mL/kg IM As medically necessary
Transplant prophylaxis Up to 20,000 IU per protocol IV With documented medical necessity

Quantity Limit Overrides

For doses exceeding standard limits, provide:

  • Clinical rationale for increased dosing
  • Reference to published protocols
  • Monitoring plan for treatment response

Required Documentation

Clinician Corner: Medical Necessity Letter Checklist

Your prescriber's letter should include:

✓ Patient demographics and insurance information
✓ Exposure details: date, type, circumstances
✓ Source information: HBsAg status if known
✓ Patient's hepatitis B status: vaccination history, serology results
✓ Clinical rationale: why HyperHEP is necessary vs. vaccination alone
✓ Timing justification: reference to CDC's treatment windows
✓ Dosing plan: specific dose, route, monitoring
✓ Guideline citations: CDC, FDA labeling, specialty guidelines

Supporting Documents

  • Exposure incident report
  • Laboratory results (HBsAg, anti-HBs, anti-HBc)
  • Vaccination records
  • Prior treatment history
  • Relevant imaging or clinical notes

Site of Care Requirements

HyperHEP must be administered by qualified healthcare providers in appropriate clinical settings. Cigna typically requires:

Approved Sites

  • Hospital outpatient departments
  • Physician offices with appropriate facilities
  • Infusion centers
  • Emergency departments (for urgent exposures)

Restrictions

  • Home administration generally not covered
  • Out-of-network sites may result in higher costs or denials
  • Specialty pharmacy coordination may be required
Note: For emergency post-exposure treatment, hospitals may administer before authorization, with retroactive coverage review.

Appeals Process in Michigan

Michigan offers robust patient protections under the Patient's Right to Independent Review Act.

Internal Appeals (Cigna)

  1. Timeline: File within 180 days of denial
  2. Process: Submit additional clinical evidence
  3. Review: Cigna has defined timeframes for response
  4. Expedited: Available for urgent cases with physician attestation

External Review (Michigan DIFS)

  1. Timeline: File within 127 days of final internal denial
  2. Process: Submit External Review Request to Michigan DIFS
  3. Review: Independent medical experts review within 60 days
  4. Expedited: 72-hour review for urgent cases
  5. Contact: Michigan DIFS at 877-999-6442
From our advocates: "We've seen Michigan external reviews frequently overturn denials for time-sensitive treatments like HyperHEP when providers clearly document the exposure risk and cite CDC guidelines. The key is comprehensive clinical documentation submitted promptly."

Common Denial Reasons and Solutions

Denial Reason Solution Required Documentation
"Not medically necessary" Submit CDC guideline references and exposure documentation Incident report, source HBsAg status, timing
"Outside treatment window" Document urgent clinical need and cite expanded CDC windows Clinical justification for delayed treatment
"Vaccination sufficient" Explain why passive immunity needed Patient's immune status, exposure risk level
"Non-formulary drug" Request formulary exception with clinical rationale Medical necessity letter, alternative failures
"Quantity limit exceeded" Provide dosing justification based on guidelines Weight-based calculations, protocol references

When to Get Help

If you're struggling with coverage issues, Counterforce Health specializes in turning insurance denials into successful appeals for specialty medications like HyperHEP. Their platform analyzes denial letters and creates targeted, evidence-backed appeals that align with payer policies and clinical guidelines.

For additional support, contact Michigan DIFS at 877-999-6442 for help navigating the appeals process.

FAQ

How long does Cigna prior authorization take for HyperHEP? Standard review is completed within 72 hours. Expedited review for urgent cases is completed within 24 hours when physician urgency is documented.

What if HyperHEP is not on Cigna's formulary? Your prescriber can request a formulary exception by demonstrating medical necessity and explaining why covered alternatives are inappropriate.

Can I get an expedited appeal in Michigan? Yes, both Cigna internal appeals and Michigan DIFS external reviews offer expedited processes for urgent cases requiring physician attestation of medical urgency.

Does step therapy apply to HyperHEP? Generally no for acute post-exposure use, but some plans may require documentation that hepatitis B vaccination alone is insufficient for the patient's situation.

What happens if I miss the appeal deadline? Michigan allows 127 days for external review requests, which is longer than the federal 120-day standard. Contact DIFS immediately if you're near the deadline.

How much does HyperHEP cost without insurance? Retail prices vary by vial size and location, ranging from approximately $129 to $900+ per vial. Check with Grifols for patient assistance programs.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance representative for guidance specific to your situation. Coverage policies and procedures may change; verify current requirements with your plan and state regulators.

The process of appealing insurance denials can be complex, but Counterforce Health's specialized platform helps patients and providers navigate these challenges with targeted, evidence-based appeals that improve approval rates for medically necessary treatments.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.